Skip to main content
. 2010 Jul 29;11(1):104. doi: 10.1186/1465-9921-11-104

Figure 1.

Figure 1

Real time PCR (TaqMan®) analysis showing the quantity of oxytocin receptor normalized to 18 S and relative to untreated in primary human airway smooth muscle cells from normal donors when treated with IL-13 or IL-13R130Q (A) and TNFα (B) for 6 hr and 18 hr. * Significant difference between treated and untreated conditions (p < 0.05), but not between the two treated conditions; **Significant difference between treated and untreated conditions (p < 0.05), as well as between the two treated conditions.